- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
A health professional received a promotional Parkinson’s magazine by email despite asking to be removed from mailing lists. PMCPA found breaches for…
A UK health professional alleged a Praluent website banner broadened the licence and promoted off-label. The PMCPA Panel found the claim aligned…
A melanoma patient booklet was found balanced on treatment/testing, but breached the Code because “in association with” Melanoma UK was ambiguous and…
UK employees ‘liked’ a US colleague’s LinkedIn post about positive Opdivo Phase 3 data in upper GI cancers. The Panel said this…
RCGP Overdiagnosis Group challenged a Pfizer/BMS Eliquis email promoting AF pulse checks at flu clinics for over-65s, alleging omission of UK NSC…
A Novartis employee ‘liked’ a Cosentyx study headline on LinkedIn. PMCPA ruled POM promotion to the public plus missing INN and certification…
Ever Pharma challenged Britannia’s use of an 0844 business-rate number for APO-go support. Panel found the helpline was in scope but ruled…
PMCPA found breaches on Trixeo HCP website: generic name too small on mobile, PI not one-click on mobile, site not certified for…
A corporate website page about Efient and Lixiana was accidentally left externally accessible via site search. PMCPA ruled promotion of POMs to…
LEO discovered four cross-border transfers of value involving three UK patient organisations. Three 2019 payments were disclosed late and two agreements weren’t…
AAA-funded third-party CPD (with UK CPD accreditation) was found to include promotional claims for an unlicensed PSMA therapy. PMCPA ruled breaches for…
Anonymous HCP challenged multiple Roche Resources pages. Panel upheld breaches for illegible Gazyvaro generic name and misleading Ocrevus “dosed every 6 months”…
A senior leader emailed staff urging donations to SMA charities, describing “partnering” to “put pressure on the NHS” to fund Spinraza after…
PMCPA ruled Daiichi Sankyo breached Clauses 8.1 and 8.3 after desktop and mobile versions of Lixiana HCP/patient webpages differed (colour and images)…
A UK health professional complained that the Ajovy website entry pop-up lacked the generic name and black triangle. The Panel ruled no…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.